Epigenetic mechanisms of behavioural, placental and cognitive impairment in a neurodevelopmental model for schizophrenia

Lead Research Organisation: University of Manchester
Department Name: School of Biological Sciences

Abstract

A fundamental unknown in understanding mechanisms of disease, and therefore improving therapy, is how stressors experienced during critical developmental periods influence the genesis or 'programming' of adult disease (Estes & McAllister 2016). In particular, stressors experienced during pregnancy may increase the likelihood of the offspring developing cognitive disorders across the lifespan (Knuessel et al. 2014). It is most likely that this induces a vulnerability which leads to social stressors experienced during adolescence exacerbating an existing phenotype and neuropathology. Whether this relates to changes directly affecting brain development in utero, altered maternal behaviour, adolescent brain development or a combination of these, is unclear. Further, the mechanisms underlying such effects remain poorly defined.

Maternal stressors result in epigenetic modifications (DNA methylation and histone modifications) in placental tissue and offspring brain, and are likely to be key candidate mechanisms leading to altered gene expression and thus developmental changes in the brain resulting in cognitive and behavioural disturbances (Akbarian 2014).

The placenta plays a crucial role in maternal-fetal interactions, the modulation of fetal adaptive responses may lead to an increased susceptibility to development of neuropsychiatric disease later in life. Placental development is affected by maternal stressors, but how this links to cognitive impairment in offspring is unclear. Recent genome-wide association studies have identified risk factor genes for schizophrenia which adversely affect placentation (Ursini et al. 2018) and a link between reduced placenta weight and increased risk for schizophrenia has been identified (Wahlbeck et al. 2001). We propose that epigenetic mechanisms mediate the effects of maternal stressors on placental function leading to altered brain development and later impaired cognitive development.

The proposed project capitalizes on our recently established rat model of maternal immune activation (Murray et al. 2019) and seeks to investigate epigenome-by-environment interactions that link to schizophrenia development. We will use a multidisciplinary approach to map functional changes along a developmental timeline that links placental morphological and functional development with fetal brain development and adolescent environmental conditions to offspring behavioural traits. Evaluation of placental morphological development and function, molecular array studies, epigenomic and histological analyses in brain and placenta together with parent-offspring behavioural interactions, cognitive and behavioural analyses in our rodent neurodevelopmental model of schizophrenia will be conducted. The project therefore offers broad scientific training covering mammalian disease and behavioural research, histology, physiology, molecular biology, epigenetic and gene expression analyses. This multidisciplinary project will suit candidates with relevant backgrounds who wish to apply their skills to a significant research question using cutting-edge technologies

This project involves the use of a 'two-hit stressor' neurodevelopmental model for schizophrenia in rats. Altered behavioral phenotypes are associated with maternal exposure to the viral mimetic polyinosinic-polycytidylic acid (Poly I:C) given to pregnant dams which induces mIA ('first' hit). A second 'hit' involves a social stressor experienced during adolescence (maternal separation). Numerous and varied in vivo skills will be acquired by the student due to the extensive and unique skills set of the multidisciplinary project team (Neill, Hager, Harte, Gigg and Glazier).

Publications

10 25 50

Studentship Projects

Project Reference Relationship Related To Start End Student Name
BB/T008725/1 01/10/2020 30/09/2028
2442020 Studentship BB/T008725/1 01/10/2020 30/09/2024 Francesca McEwan